Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 11 - 20 of 108

Selected Filters:
13 August 2025

Will Lenacapavir be a lever or a let-down? Lessons, Resources, and Considerations for Implementation in the United States

Lenacapavir for PrEP has tremendous potential to increase access and engagement in the United States, reaching individuals who have been unable to embrace PrEP in its previous formulations. How can we ensure that our implementation lifts up, rather than lets down, individuals and communities who need this innovation most? What can we learn from past…

Community/Advocacy, Service Delivery

Event
7 August 2025

Town-Hall – Launch of Key Populations Long-Acting PrEP Demand Forecast

See full slide deck here Join Global Black Gay Men Connect for the official launch of the Key Populations (KP) Long-Acting PrEP Demand Forecast, developed by GBGMC and AVAC in collaboration with Avenir Health. This virtual town hall will spotlight the critical findings of the new forecast, which estimates the future need for long-acting PrEP…

Community/Advocacy, Research, Service Delivery

Event
10 June 2025

Embracing Task Shifting and Innovation to Support Expanded Access to Long-Acting Injectable PrEP

Join The Choice Agenda and colleagues on June 26 for an inspiring discussion on task shifting and innovation related to improving PrEP access – injectable and otherwise. Moderator: Rupa Patel, Washington University in St. Louis Speakers: Kevin Aloysius, Legacy Community Health, Houston Megan Dieterich, Whitman-Walker Health, Washington, DC Juan Carlos Loubriel, Whitman-Walker Health, Washington, DC…

Service Delivery

Event
5 March 2025

2024 Q4 Global PrEP Tracker

AVAC’s Global PrEP Tracker offers two views on PrEP uptake around the world. Visit data.prepwatch.org for a dynamic map-based tool to explore trends in oral PrEP use globally as countries introduce and scale up PrEP programs. For insights on the full scope of PrEP use around the world, the PrEP Tracker as a spreadsheet offers…

Monitoring & Evaluation

Spreadsheet
3 February 2025

Interest in Injectable and Oral PrEP for HIV Prevention Among Women and Men Who Inject Drugs

This article from Journal of Addiction Medicine examines interests and concerns around use of oral and injectable PrEP amongst people who inject drugs in the United States.

Research

External Link
21 January 2025

PrEP Booklet of Frequently Asked Questions (FAQs): A Peer Outreach Worker Tool

This tool was developed to be used by peer outreach workers, peer educators, and other community-based health providers to help provide comprehensive information about pre-exposure prophylaxis (PrEP) to key population peers.

Community/Advocacy, Demand Creation/Marketing

Document
16 December 2024

Understanding the Drivers of CAB PrEP Uptake and Use among Women in sub-Saharan Africa to Build Demand for New PrEP Methods

This article from Current HIV/AIDS Reports reviews facilitators and barriers to use of injectable cabotegravir (CAB) for PrEP by women in sub-Saharan Africa.

Demand Creation/Marketing, Research, Service Delivery

External Link
3 December 2024

Gears of Lenacapavir for PrEP Rollout

This report provides a framework for accelerated and equitable introduction of injectable lenacapavir (LEN) for PrEP, including outlining priority actions for different stakeholder groups.

Community/Advocacy, Financing & Costing, Research, Service Delivery

Document
29 November 2024

Daily Oral PrEP, PrEP Ring, and CAB PrEP Template Guidelines (Spanish)

The intent of this document is to provide adaptable guidelines to support the development and adoption of national guidelines that align with World Health Organization (WHO) pre-exposure prophylaxis (PrEP) recommendations and guidance, including those for tenofovir disoproxil fumarate (TDF)-based oral PrEP, the monthly dapivirine vaginal ring (“PrEP ring” or “the ring”), and injectable cabotegravir (CAB…

Normative Guidance/Policies

Document
29 November 2024

HIV Prevention User Journey Tool

The HIV Prevention Journey Tool was developed to support adolescent girls and young women to explore methods that would align with their lifestyle, needs and personal preferences; and support healthcare providers to provide informed counseling based on client needs. The digital tool, which has been optimized for use on mobile devices, can be accessed here.…

Demand Creation/Marketing, Service Delivery

Document